Eight in 10 now survive skin cancer

July 22, 2013, Cancer Research UK

(Medical Xpress)—More than eight out of 10 people diagnosed with malignant melanoma, the most dangerous form of skin cancer, will now survive the disease, compared to only around five in 10 in the early 70s, according to a new report from Cancer Research UK.

Ten year survival has reached 80 per cent in men and 90 per cent in women, compared to 38 per cent in men and 58 per cent in women 40 years ago. The improvements in are likely to be down to improvements in treatment, early and awareness of the symptoms.

Nearly 13,000 cases of melanoma are diagnosed each year in the UK, that's around 35 people every day.

Professor Richard Marais, director of the Cancer Research UK Paterson Institute for Cancer Research based at the University of Manchester, said: "Forty years ago, only around half of those diagnosed with were surviving, so eight out of 10 is a massive improvement. More and more people are beating skin cancer but we can't stop there and we need to develop better treatments for the two out of 10 where things don't look so good.

"Obviously we've come a long way in the fight against skin cancer and that's largely down to the of supporters who have funded research to help us to understand the disease better and find new ways of beating it. Research funded by Cancer Research UK has underpinned the development of new drugs like vemurafenib. Although these drugs do not cure skin cancers, they can give patients with advanced melanoma valuable extra months and show the progress we are making."

Dr Harpal Kumar, Cancer Research UK's chief executive, said: "Our research is revealing more about skin cancer: what causes it, how we can better prevent it and how we can develop targeted treatments to help more people beat the disease. By funding more research we can bring forward the day when even more people survive.

"Cancer Research UK research was behind the discovery that faults in a gene called BRAF contribute to over half of all cases of . Since then, our scientists have led efforts to develop drugs that target this gene.

"Skin cancer is one of the fastest rising cancers in the UK, which is likely to be down to our sunbathing habits and the introduction of cheap package holidays in previous decades. But the earlier cancer is detected, the easier it is to treat it and the more likely the treatment is to be successful. That's why it's important to get to know your skin and if you notice anything unusual, such as a change to a mole or a blemish that still hasn't healed after a few weeks, then get it checked out by your GP."

Explore further: Genome sequencing reveals mucosal melanoma's bullseye

More information: www.cancerresearchuk.org/cance … cerstats/types/skin/

Related Stories

Genome sequencing reveals mucosal melanoma's bullseye

June 7, 2013
(Medical Xpress)—Scientists may have found a molecular 'bullseye' for a rare form of melanoma, opening up opportunities for new targeted treatment, according to new research being published in the Journal of Pathology today ...

Early results show two drugs may be better than one to treat most deadly skin cancer

February 12, 2013
Adding lung cancer drugs to targeted melanoma treatment could increase survival for certain patients, according to research published in Cancer Discovery today.

Genetic screen finds new treatment targets for lung cancer

July 9, 2013
Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research ...

Shape-shifting cells help skin cancer spread

June 10, 2013
(Medical Xpress)—Scientists have discovered genes that control shape changes in melanoma skin cancer cells, allowing them to wriggle free and spread around the body, according to new research published in Nature Cell Biology.

Diabetes treatment doubles skin cancer drug's effectiveness

April 2, 2012
Combining the experimental drug Avastin (bevacizumab) with the diabetes drug Metformin almost doubles its ability to reduce skin cancer growth, according to a study in Cancer Discovery.

Study suggests patients should be screened before receiving vemurafenib

August 14, 2012
Different genetic mistakes driving skin cancer may affect how patients respond to the drug vemurafenib, providing grounds to screen people with melanoma skin cancer before treatment, a new study by Cancer Research UK scientists ...

Recommended for you

T-cells engineered to outsmart tumors induce clinical responses in relapsed Hodgkin lymphoma

January 16, 2018
WASHINGTON-(Jan. 16, 2018)-Tumors have come up with ingenious strategies that enable them to evade detection and destruction by the immune system. So, a research team that includes Children's National Health System clinician-researchers ...

More evidence of link between severe gum disease and cancer risk

January 16, 2018
Data collected during a long-term health study provides additional evidence for a link between increased risk of cancer in individuals with advanced gum disease, according to a new collaborative study led by epidemiologists ...

Researchers identify new treatment target for melanoma

January 16, 2018
Researchers in the Perelman School of Medicine at the University of Pennsylvania have identified a new therapeutic target for the treatment of melanoma. For decades, research has associated female sex and a history of previous ...

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.